These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20128003)

  • 1. Response to Baumgart review.
    Feagan BG; Parikh A;
    Inflamm Bowel Dis; 2010 Sep; 16(9):1449. PubMed ID: 20128003
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of inflammatory bowel disease: past, present and future.
    Keyashian K; Annunziata ML; Sakuraba A; Hanauer S
    Expert Rev Clin Immunol; 2012 May; 8(4):303-5. PubMed ID: 22607175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Crohn's Disease - New Therapies].
    Klag T; Wehkamp J
    Dtsch Med Wochenschr; 2018 Jul; 113(13):953-959. PubMed ID: 29972839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology evaluation: MRA, Chugai.
    Ding C; Jones G
    Curr Opin Mol Ther; 2003 Feb; 5(1):64-9. PubMed ID: 12669473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease?
    Rhee SJ; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):211-3. PubMed ID: 12916502
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
    Nishimoto N
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):221-30. PubMed ID: 16129906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of biologic therapy for Crohn's disease.
    Dryden GW
    Expert Opin Biol Ther; 2009 Aug; 9(8):967-74. PubMed ID: 19591627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoapheresis in Crohn's disease: the final curtain?
    Peyrin-Biroulet L; Danese S
    Gut; 2013 Apr; 62(4):487-8. PubMed ID: 22892296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effectiveness of short-term administration of monoclonal antibody cA2 against tumor necrosis factor alpha in Crohn disease].
    Schreiber S; Koop I
    Z Gastroenterol; 1998 Apr; 36(4):349-51. PubMed ID: 9612932
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab induces and maintains remission in severe, resistant paediatric Crohn disease.
    Hadziselimovic F
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):208-11. PubMed ID: 18223382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn disease. A survey of a Cochrane review].
    Al-Subeihe I; Nielsen OH
    Ugeskr Laeger; 2008 Dec; 170(50):4130-4. PubMed ID: 19091193
    [No Abstract]   [Full Text] [Related]  

  • 12. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 13. The changing face of treatment for Crohn's disease.
    Vermeire S; Rutgeerts P
    Br J Surg; 2006 Apr; 93(4):385-6. PubMed ID: 16555241
    [No Abstract]   [Full Text] [Related]  

  • 14. Certolizumab pegol.
    Melmed GY; Targan SR; Yasothan U; Hanicq D; Kirkpatrick P
    Nat Rev Drug Discov; 2008 Aug; 7(8):641-2. PubMed ID: 18670430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering with interferons in inflammatory bowel disease.
    Ghosh S; Chaudhary R; Carpani M; Playford R
    Gut; 2006 Aug; 55(8):1071-3. PubMed ID: 16849343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series: does a combination of anti-tnf antibodies and transient ileal fecal stream diversion in severe Crohn's colitis with perianal fistula prevent definitive stoma?
    Uzzan M; Stefanescu C; Maggiori L; Panis Y; Bouhnik Y; Treton X
    Am J Gastroenterol; 2013 Oct; 108(10):1666-8. PubMed ID: 24091520
    [No Abstract]   [Full Text] [Related]  

  • 18. Ustekinumab for the treatment of Crohn's disease.
    Khanna R; Feagan BG
    Immunotherapy; 2013 Aug; 5(8):803-15. PubMed ID: 23902548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of stem cell therapy for Crohn's disease.
    Dryden GW
    Expert Opin Biol Ther; 2009 Jul; 9(7):841-7. PubMed ID: 19527107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel diseases--new therapeutic options].
    Herrlinger K; Stange EF
    Med Klin (Munich); 2008 Feb; 103(2):90-101; quiz 102-3. PubMed ID: 18270665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.